183 related articles for article (PubMed ID: 34351377)
1. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
[TBL] [Abstract][Full Text] [Related]
2. Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.
Greene SA; De Vuyst H; John-Stewart GC; Richardson BA; McGrath CJ; Marson KG; Trinh TT; Yatich N; Kiptinness C; Cagle A; Nyongesa-Malava E; Sakr SR; Mugo NR; Chung MH
JAMA; 2019 Oct; 322(16):1570-1579. PubMed ID: 31638680
[TBL] [Abstract][Full Text] [Related]
3. Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.
De Vuyst H; Mugo NR; Franceschi S; McKenzie K; Tenet V; Njoroge J; Rana FS; Sakr SR; Snijders PJ; Chung MH
PLoS One; 2014; 9(10):e111037. PubMed ID: 25343563
[TBL] [Abstract][Full Text] [Related]
4. Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
Chung MH; De Vuyst H; Greene SA; Topazian HM; Sayed S; Moloo Z; Cagle A; Nyongesa-Malava E; Luchters S; Temmerman M; Sakr SR; Mugo NR; McGrath CJ
Int J Gynaecol Obstet; 2021 Jan; 152(1):118-124. PubMed ID: 33145753
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
Kang WD; Kim SM
Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
[TBL] [Abstract][Full Text] [Related]
7. Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.
Lince-Deroche N; van Rensburg C; Roseleur J; Sanusi B; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2018; 13(10):e0203921. PubMed ID: 30308014
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Residual/Recurrent Disease and Its Risk Factors after Loop Electrosurgical Excision Procedure for High-Grade Cervical Intraepithelial Neoplasia.
Wu J; Jia Y; Luo M; Duan Z
Gynecol Obstet Invest; 2016; 81(4):296-301. PubMed ID: 26337009
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.
Smith JS; Sanusi B; Swarts A; Faesen M; Levin S; Goeieman B; Ramotshela S; Rakhombe N; Williamson AL; Michelow P; Omar T; Hudgens MG; Firnhaber C
Am J Obstet Gynecol; 2017 Aug; 217(2):183.e1-183.e11. PubMed ID: 28366730
[TBL] [Abstract][Full Text] [Related]
10. Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure.
Orang'o EO; Emont JP; Ermel AC; Liu T; Omodi V; Tong Y; Itsura PM; Tonui PK; Maina T; Ong'echa JM; Muthoka K; Kiptoo S; Moormann A; Hogan J; Loehrer PJ; Brown D; Cu-Uvin S
Int J Gynaecol Obstet; 2020 Nov; 151(2):279-286. PubMed ID: 32715467
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
Wilkin T; Chen H; Sahasrabuddhe V; Matining R; Mngqibisa R; Chinula L; Mbilizi Y; Magure T; Omoz-Oarhe AE; Rassool M; Riviere C; Bhosale R; Godbole S; Naranjo R; Coombs R; Michelow P; Godfrey C; Firnhaber C
Clin Infect Dis; 2022 Oct; 75(8):1280-1288. PubMed ID: 35294524
[TBL] [Abstract][Full Text] [Related]
12. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2013 Aug; 130(2):264-8. PubMed ID: 23623831
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
[TBL] [Abstract][Full Text] [Related]
14. Loop Electrosurgical Excision Procedure Treats Cervical Intraepithelial Neoplasia 2/3 Among HIV- and HIV+ Women in Kenya.
Orang'o O; Mehta N; Itsura P; Tonui P; Bussmann H; Bogers JP; Liu T; Cu-Uvin S
J Low Genit Tract Dis; 2020 Jan; 24(1):21-26. PubMed ID: 31860571
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
[TBL] [Abstract][Full Text] [Related]
16. The value of endocervical curettage during loop electrosurgical excision procedures in predicting persistent/recurrent preinvasive cervical disease.
Cuello MA; Espinosa ME; Orlandini EJ; Hwang DY
Int J Gynaecol Obstet; 2018 Jun; 141(3):337-343. PubMed ID: 29509961
[TBL] [Abstract][Full Text] [Related]
17. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure.
Kang WD; Oh MJ; Kim SM; Nam JH; Park CS; Choi HS
Am J Obstet Gynecol; 2010 Jul; 203(1):72.e1-6. PubMed ID: 20417477
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
[TBL] [Abstract][Full Text] [Related]
19. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
20. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure.
Cecchini S; Carozzi F; Confortini M; Zappa M; Ciatto S
Tumori; 2004; 90(2):225-8. PubMed ID: 15237586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
